Balance Sheet
Cash Flow Statement
AmortizationAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Cash from Operations (2024 - 2025)

Historic Cash from Operations for Dr Reddys Laboratories (RDY) over the last 3 years, with Q3 2025 value amounting to $178.5 million.

  • Dr Reddys Laboratories' Cash from Operations rose 6047.91% to $178.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $562.5 million, marking a year-over-year increase of 5492.87%. This contributed to the annual value of $779.0 million for FY2025, which is 89.06% down from last year.
  • Per Dr Reddys Laboratories' latest filing, its Cash from Operations stood at $178.5 million for Q3 2025, which was up 6047.91% from $170.9 million recorded in Q2 2025.
  • Dr Reddys Laboratories' 5-year Cash from Operations high stood at $178.5 million for Q3 2025, and its period low was $101.8 million during Q2 2024.